CID 101944491

Irbesartan metabolite 1

Structural Information

Molecular Formula
C25H28N6O3
SMILES
CC(CCC1=NC2(CCC(C2)O)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)O
InChI
InChI=1S/C25H28N6O3/c1-16(32)6-11-22-26-25(13-12-19(33)14-25)24(34)31(22)15-17-7-9-18(10-8-17)20-4-2-3-5-21(20)23-27-29-30-28-23/h2-5,7-10,16,19,32-33H,6,11-15H2,1H3,(H,27,28,29,30)
InChIKey
LIDZWACDVHJFLD-UHFFFAOYSA-N
Compound name
8-hydroxy-2-(3-hydroxybutyl)-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

460.2223 Da
Monoisotopic Mass

1.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 461.22958 208.3
[M+Na]+ 483.21152 219.2
[M+NH4]+ 478.25612 213.0
[M+K]+ 499.18546 218.4
[M-H]- 459.21502 211.1
[M+Na-2H]- 481.19697 215.1
[M]+ 460.22175 210.4
[M]- 460.22285 210.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.